STAT June 30, 2021
Helen Branswell

The extraordinary drive to develop Covid-19 vaccines was like a moonshot — and like that fabled acceleration of space exploration science, it delivered. Just a little over six months after the first Covid vaccines were authorized for use, nearly 3 billion vaccine doses have been administered around the globe.

The world got very lucky; so much went right in the quest for vaccines to end this pandemic. But there have been setbacks (see: Sanofi) and failures (see: Merck) along the way, and the progress toward supplying vaccine to less affluent parts of the world has been scandalously slow.

As life begins to return to normal — at least in countries with access to vaccines — STAT wanted to take stock...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
How To Prevent Alzheimer’s Disease: A Case For Vaccines
Obesity drugs could bankrupt US healthcare, says Sanders
First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial
US Pharma and Biotech Summit 2024: A Biotech Industry Overview
AstraZeneca antibody reduced Covid-19 risk in immunocompromised

Share This Article